Combating Illicit Xylazine Act

U.S. Congress · HR1266 · In Committee

Progression

Timing in context

Primary sponsor's contributions received (same period)

Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.

What the bill says

HR1266 · U.S. Congress · In Committee

Introduced 2025-02-12. Latest action: Forwarded by Subcommittee to Full Committee by Voice Vote.

View on Congress.gov →

Sponsors

Text versions

  • Introduced in House — 2025-02-12 — XML

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2026-06-25Subcommittee Consideration and Mark-up Session Held
2026-06-25Forwarded by Subcommittee to Full Committee by Voice Vote.
2025-02-12Introduced in House
2025-02-12Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-12Referred to the Subcommittee on Health.

← Back to legislation